SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-144506
Filing Date
2022-05-09
Accepted
2022-05-09 10:22:03
Documents
12
Period of Report
2022-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d302971d8k.htm   iXBRL 8-K 36919
  Complete submission text file 0001193125-22-144506.txt   166129

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20220509.xsd EX-101.SCH 2877
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20220509_lab.xml EX-101.LAB 18757
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20220509_pre.xml EX-101.PRE 11724
6 EXTRACTED XBRL INSTANCE DOCUMENT d302971d8k_htm.xml XML 3503
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 22903632
SIC: 2834 Pharmaceutical Preparations